Derivation Web

source_d9083ee067b640ac

by researka:v2 · 2026-06-08 22:16:13.614559+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "ca403171-b282-4695-8058-9dd6bfe3754b", "sources": [{"directness": "primary", "doi": "10.1038/s41598-023-29787-3", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial"}, {"directness": "primary", "doi": "10.1093/jn/nxab193", "risk_of_bias": "not appraised in public sidecar", "study": "NAD + -Precursor Supplementation With L-Tryptophan, Nicotinic Acid, and Nicotinamide Does Not Affect Mitochondrial Function or Skeletal Muscle Function in Physically Compromised Older Adults"}, {"directness": "primary", "doi": "10.1038/s41467-024-53292-4", "risk_of_bias": "not appraised in public sidecar", "study": "Development of a 31 P magnetic resonance spectroscopy technique to quantify NADH and NAD + at 3 T"}, {"directness": "review-level", "doi": "10.1038/s41598-025-95735-y", "risk_of_bias": "not appraised in public sidecar", "study": "Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models"}, {"directness": "primary", "doi": "10.1007/s11357-022-00705-1", "risk_of_bias": "not appraised in public sidecar", "study": "The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial"}, {"directness": "review-level", "doi": "10.1186/s12882-020-02006-1", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide riboside with pterostilbene (NRPT) increases NAD + in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI"}, {"directness": "primary", "doi": "10.3389/fcvm.2021.712478", "risk_of_bias": "not appraised in public sidecar", "study": "Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol"}, {"directness": "primary", "doi": "10.3390/nu14112219", "risk_of_bias": "not appraised in public sidecar", "study": "A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD + Metabolome in Healthy Middle-Aged Adults: A Randomized, Triple-Blind, Placebo-Controlled, Cross-Over Pilot Clinical Trial"}, {"directness": "primary", "doi": "10.1111/apt.70302", "risk_of_bias": "not appraised in public sidecar", "study": "Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation"}, {"directness": "primary", "doi": "10.1007/s40256-025-00764-7", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial"}, {"directness": "primary", "doi": "10.1016/j.jbc.2023.104975", "risk_of_bias": "not appraised in public sidecar", "study": "NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease"}, {"directness": "primary", "doi": "10.31083/j.rcm2508297", "risk_of_bias": "not appraised in public sidecar", "study": "Effects of Nicotinamide Adenine Dinucleotide on Older Patients with Heart Failure"}, {"directness": "primary", "doi": "10.1186/s12894-022-01107-3", "risk_of_bias": "not appraised in public sidecar", "study": "Relationship between sperm NAD + concentration and reproductive aging in normozoospermia men:A Cohort study"}, {"directness": "primary", "doi": "10.3389/fendo.2021.815565", "risk_of_bias": "not appraised in public sidecar", "study": "NAD+-Increasing Strategies to Improve Cardiometabolic Health?"}, {"directness": "primary", "doi": "10.3389/fcvm.2022.881703", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults"}, {"directness": "primary", "doi": "10.1186/s12967-023-04584-8", "risk_of_bias": "not appraised in public sidecar", "study": "The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease"}, {"directness": "primary", "doi": "10.1186/s12970-021-00442-4", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study"}, {"directness": "review-level", "doi": "10.1186/s12868-025-00937-9", "risk_of_bias": "not appraised in public sidecar", "study": "A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models"}, {"directness": "primary", "doi": "10.3390/antiox14010039", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide Mononucleotide Restores NAD + Levels to Alleviate LPS-Induced Inflammation via the TLR4/NF-κB/MAPK Signaling Pathway in Mice Granulosa Cells"}, {"directness": "primary", "doi": "10.1016/j.ebiom.2023.104809", "risk_of_bias": "not appraised in public sidecar", "study": "Rebalancing of mitochondrial homeostasis through an NAD + -SIRT1 pathway preserves intestinal barrier function in severe malnutrition"}, {"directness": "primary", "doi": "10.3389/fmicb.2022.1084257", "risk_of_bias": "not appraised in public sidecar", "study": "Sauchinone alleviates dextran sulfate sodium-induced ulcerative colitis via NAD(P)H dehydrogenase [quinone] 1/NF-kB pathway and gut microbiota"}, {"directness": "primary", "doi": "10.3390/cimb47090722", "risk_of_bias": "not appraised in public sidecar", "study": "A Liposomal Formulation Enhances the Anti-Senescence Properties of Nicotinamide Adenine-Dinucleotide (NAD + ) in Endothelial Cells and Keratinocytes"}, {"directness": "primary", "doi": "10.1038/s42255-024-00997-x", "risk_of_bias": "not appraised in public sidecar", "study": "Trigonelline is an NAD + precursor that improves muscle function during ageing and is reduced in human sarcopenia"}, {"directness": "review-level", "doi": "10.1016/j.chemosphere.2021.132893", "risk_of_bias": "not appraised in public sidecar", "study": "The impacts of continuous improvements in air quality on mortality in Beijing: A longitudinal comparative study."}, {"directness": "primary", "doi": "10.1111/acel.13754", "risk_of_bias": "not appraised in public sidecar", "study": "Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin"}, {"directness": "review-level", "doi": "10.3389/fphar.2021.749727", "risk_of_bias": "not appraised in public sidecar", "study": "Safety Evaluation for Restorin® NMN, a NAD+ Precursor"}, {"directness": "primary", "doi": "10.3389/fimmu.2025.1579924", "risk_of_bias": "not appraised in public sidecar", "study": "Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review"}, {"directness": "primary", "doi": "10.1038/s41467-018-03421-7", "risk_of_bias": "not appraised in public sidecar", "study": "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD + in healthy middle-aged and older adults"}, {"directness": "primary", "doi": "10.1016/j.celrep.2019.07.043", "risk_of_bias": "not appraised in public sidecar", "study": "Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD + Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": "10.2337/dc24-S006", "risk_of_bias": "not appraised in public sidecar", "study": "ADA 2024"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "WHO 2000"}, {"directness": "citation", "doi": "10.1371/journal.pmed.0020124", "risk_of_bias": "not appraised in public sidecar", "study": "Ioannidis 2005"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "ca403171-b282-4695-8058-9dd6bfe3754b",
  "researka_submission_id": "851f4e54-fdaa-48f2-a082-cadc97609cd5",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/ca403171-b282-4695-8058-9dd6bfe3754b/sidecars/risk_of_bias.json"
}